Erismodegib is a potent small-molecule Hedgehog pathway antagonist utilized primarily in the treatment of advanced basal cell carcinoma and other solid tumors sensitive to this signaling pathway. Analytical… Read more





Erismodegib is a potent small-molecule Hedgehog pathway antagonist utilized primarily in the treatment of advanced basal cell carcinoma and other solid tumors sensitive to this signaling pathway. Analytical laboratories require high-quality Erismodegib reference standards to perform rigorous impurity profiling, method validation, and ongoing quality control of the active pharmaceutical ingredient. This category encompasses essential compounds for such analysis, including the pharmacologically active Erismodegib diphosphate salt and identified drug metabolites like M48. Additionally, the collection features stable isotope labelled compounds, such as Erismodegib-d4 and deuterated impurity standards, which are critical for accurate quantification using liquid chromatography-mass spectrometry. The inclusion of potential degradation products, such as N-nitroso impurities, ensures that analytical testing protocols can effectively monitor safety and stability throughout the manufacturing and regulatory compliance process for this specific therapeutic agent.